The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENDOCET 10-325 MG TABLET 100S. The contract has a potential value of $4,350.72 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this order, which falls under an existing indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Generated 5/3/24, 9:49 AM